215 related articles for article (PubMed ID: 12679307)
1. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer.
García I; Vizoso F; Martín A; Sanz L; Abdel-Lah O; Raigoso P; García-Muñiz JL
Ann Surg Oncol; 2003 Apr; 10(3):234-41. PubMed ID: 12679307
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor and c-erbB-2 contents in unresectable (UICC R1 or R2) gastric cancer.
García I; del Casar JM; Corte MD; Allende MT; García-Muñiz JL; Vizoso F
Int J Biol Markers; 2003; 18(3):200-6. PubMed ID: 14535591
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of epidermal growth factor receptor content in gastric cancer.
García I; Vizoso F; Andicoechea A; Raigoso P; Vérez P; Alexandre E; García-Muñiz JL; Allende MT
Int J Biol Markers; 2001; 16(3):183-8. PubMed ID: 11605731
[TBL] [Abstract][Full Text] [Related]
4. C-erbB-2 oncoprotein content in colorectal cancer and in surrounding mucosa: relationship with clinicopathologic parameters and prognostic significance.
Vizoso F; Villar C; Rodríguez JC; Raigoso P; García-Muñiz JL; Allende MT; García-Moran M
Int J Surg Investig; 2000; 1(6):483-93. PubMed ID: 11729856
[TBL] [Abstract][Full Text] [Related]
5. Human epidermal growth factor receptor 2-, epidermal growth factor receptor-, and mesenchymal epithelial transition factor-positive sites of gastric cancer using surgical samples.
Oono Y; Kuwata T; Takashima K; Shinmura K; Hori K; Yoda Y; Ikematsu H; Shitara K; Kinoshita T; Yano T
Gastric Cancer; 2019 Mar; 22(2):335-343. PubMed ID: 29951752
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma.
Kim H; Seo S; Kim K; Park YH; An M; Baik H; Choi C; Oh S
World J Surg Oncol; 2019 Jul; 17(1):122. PubMed ID: 31296222
[TBL] [Abstract][Full Text] [Related]
7. Multicenter large-scale study of prognostic impact of HER2 expression in patients with resectable gastric cancer.
Kurokawa Y; Matsuura N; Kimura Y; Adachi S; Fujita J; Imamura H; Kobayashi K; Yokoyama Y; Shaker MN; Takiguchi S; Mori M; Doki Y
Gastric Cancer; 2015 Oct; 18(4):691-7. PubMed ID: 25224659
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
[TBL] [Abstract][Full Text] [Related]
9. Preferential HER2 expression in liver metastases and EGFR expression in peritoneal metastases in patients with advanced gastric cancer.
Saito T; Nakanishi H; Mochizuki Y; Ito S; Ito Y; Misawa K; Yatabe Y; Yamamichi K; Kondo E
Gastric Cancer; 2015 Oct; 18(4):711-9. PubMed ID: 25173363
[TBL] [Abstract][Full Text] [Related]
10. Membranous levels of c-erbB-2 oncoprotein in gastric cancer: their relationship with clinicopathological parameters and their prognostic significance.
Vizoso FJ; Corte MD; Alvarez A; García I; del Casar JM; Bongera M; González LO; García-Muñiz JL; Allende MT
Int J Biol Markers; 2004; 19(4):268-74. PubMed ID: 15646832
[TBL] [Abstract][Full Text] [Related]
11. Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer.
Matsubara J; Yamada Y; Hirashima Y; Takahari D; Okita NT; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
Clin Cancer Res; 2008 May; 14(10):3022-9. PubMed ID: 18483367
[TBL] [Abstract][Full Text] [Related]
12. Potential prognostic significance of p185(HER2) overexpression with loss of PTEN expression in gastric carcinomas.
Im SA; Lee KE; Nam E; Kim DY; Lee JH; Han HS; Seoh JY; Park HY; Cho MS; Han WS; Lee SN
Tumori; 2005; 91(6):513-21. PubMed ID: 16457151
[TBL] [Abstract][Full Text] [Related]
13. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.
Phillips BE; Tubbs RR; Rice TW; Rybicki LA; Plesec T; Rodriguez CP; Videtic GM; Saxton JP; Ives DI; Adelstein DJ
Dis Esophagus; 2013 Apr; 26(3):299-304. PubMed ID: 22676551
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of major receptor tyrosine kinase expression in gastric cancer.
Kurokawa Y; Matsuura N; Kawabata R; Nishikawa K; Ebisui C; Yokoyama Y; Shaker MN; Hamakawa T; Takahashi T; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S584-90. PubMed ID: 24743909
[TBL] [Abstract][Full Text] [Related]
16. Correlation of HER2 expression with clinicopathological characteristics and prognosis in resectable gastric cancer.
Otsu H; Oki E; Ikawa-Yoshida A; Kawano H; Ando K; Ida S; Kimura Y; Aishima S; Saeki H; Morita M; Kohnoe S; Oda Y; Maehara Y
Anticancer Res; 2015 Apr; 35(4):2441-6. PubMed ID: 25862912
[TBL] [Abstract][Full Text] [Related]
17. HER2 Expression Status and Prognostic, Diagnostic, and Demographic Properties of Patients with Gastric Cancer: a Single Center Cohort Study from Iran.
Feizy A; Karami A; Eghdamzamiri R; Moghimi M; Taheri H; Mousavinasab N
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1721-1725. PubMed ID: 29938472
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic value of EGFR in invasive breast cancer.
Quintela I; Corte MD; Allende MT; Vazquez J; Rodríguez JC; Bongera M; Lamelas M; Gonzalez LO; Vega A; García-Muñiz JL; Astudillo A; Vizoso F
Oncol Rep; 2005 Dec; 14(6):1655-63. PubMed ID: 16273272
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
[TBL] [Abstract][Full Text] [Related]
20. Comparative study on overexpression of HER2/neu and HER3 in gastric cancer.
Zhang XL; Yang YS; Xu DP; Qu JH; Guo MZ; Gong Y; Huang J
World J Surg; 2009 Oct; 33(10):2112-8. PubMed ID: 19636613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
